Skip to main content
Clinical Trials/NCT00881478
NCT00881478CompletedNot Applicable

Family Intervention for Obese Children Using Portion Control Strategy (F.O.C.U.S.) for Weight Control- A Randomized Controlled Trial

University of Calgary1 site in 1 country102 target enrollmentStarted: August 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
102
Locations
1
Primary Endpoint
Change in age and gender adjusted BMI z-score

Study Overview

Brief Summary

Obesity in children is a serious disease that is associated with increased mortality and decreased life expectancy. A simple tool used to assist in controlling portions (and therefore calorie intake) at mealtime would be of benefit in promoting weight maintenance and/or loss. The purpose of this study is to assess the efficacy of a family intervention using a portion control tool to help control weight in obese children. The investigators hypothesize that the use of portion control tools by the parents and child will result in a greater decrease in the child's BMI over a 6 month period compared with the control group.

Detailed Description

This study is a randomized controlled trial designed to assess the efficacy of a portion control tool to help improve body mass index in obese children over a 6 months period. This study will also assess whether this weight control strategy results in improvement of blood pressure, waist circumference, and biomarkers of obesity including plasma visfatin, adiponectin, fasting lipid profile and apolipoprotein B, liver function tests and fasting insulin and glucose. Both the intervention and the control group will receive a one hour session of standard dietary counseling from a registered dietician at baseline regarding healthy eating habits, appropriate portion sizes and the Canada Food Guide. The duration of this study will be 6 months. Baseline measurements will be taken at the initial visit and again at 3 months and 6 months. Each participants' height and weight will be measured, and BMI will be calculated. Waist circumference and blood pressure will also be measured. A blood sample will be drawn at baseline and 6 months for a fasting lipid profile, fasting insulin, and glucose levels. Measurement of plasma visfatin and adiponectin levels using ELISA will be carried out.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to 16 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •age 8 years old to 16 years old
  • •BMI greater than or equal to the 85th percentile for age and gender

Exclusion Criteria

  • •patients currently taking a weight loss medication
  • •gastrointestinal disorder
  • •psychiatric illness under the care of a psychiatrist
  • •Cushing's syndrome
  • •hypothalamic or genetic etiology of obesity
  • •uncontrolled or untreated thyroid disease
  • •current diagnosis of cancer
  • •history of an eating disorder such as bulimia or anorexia nervosa
  • •surgery in the past 3 months
  • •surgery planned in the ensuing 6 months
  • •any chronic illness that could affect weight status

Arms & Interventions

Nutrition counselling alone

Active Comparator

Nutrition counseling session with registered dietician

Intervention: Nutrition counseling (Other)

Nutrition counselling + portion control

Experimental

Nutrition counseling with registered dietician in addition to teaching about use of a portion control tool

Intervention: Nutrition counseling + portion control tool (Other)

Outcomes

Primary Outcomes

Change in age and gender adjusted BMI z-score

Time Frame: 6 months

Secondary Outcomes

  • Change in age and gender adjusted blood pressure percentile(6 months)
  • Change in plasma visfatin level(6 months)
  • Proportion of children achieving a BMI below the 85th percentile for age and gender(6 months)
  • Change in age and gender adjusted waist circumference percentile(6 months)
  • Change in fasting lipid profile(6 months)
  • Change in fasting insulin and fasting glucose(6 months)
  • Change in plasma adiponectin level(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Josephine Ho

Assistant Professor, Faculty of Medicine

University of Calgary

Study Sites (1)

Loading locations...

Similar Trials

Family Intervention for Obese Children... | Clinical Trial